• NeuroVive receives research grant from Vinnova pharmaasia
    June 07, 2017
    NeuroVive Pharmaceutical AB announced that the company receives close to 1 million SEK in a research grant from Swedish innovation agency, Vinnova, for developing a new treatment for genetic mitochondrial diseases.
PharmaSources Customer Service